Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Verona Pharma Q2 EPS $0.13 Beats $0.04 Estimate, Sales $103.138M Beat $92.140M Estimate

Author: Benzinga Newsdesk | August 06, 2025 04:48pm
Verona Pharma (NASDAQ:VRNA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.04 by 209.52 percent. This is a 116.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $103.138 million which beat the analyst consensus estimate of $92.140 million by 11.94 percent.

Posted In: VRNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist